Measuring response to treatment in axial spondyloarthritis using quantitative imaging biomarkers: a prospective observational cohort study

被引:2
作者
Jones, Alexis [1 ]
Bray, Timothy J. P. [2 ]
Sakai, Naomi S. [2 ]
Bainbridge, Alan J. P. [3 ]
Ciurtin, Coziana [1 ]
Hall-Craggs, Margaret A. [2 ]
机构
[1] Univ Coll London Hosp NHS Fdn Trust, Dept Rheumatol, London, England
[2] UCL, Ctr Med Imaging, London, England
[3] Univ Coll London Hosp, Dept Med Phys & Biomed Engn, London, England
关键词
ANKYLOSING-SPONDYLITIS; RESEARCH CONSORTIUM; DISEASE-ACTIVITY; INDEX; MRI;
D O I
10.1259/bjr.20220530
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Objective assessments of disease activity and response to treatment in axial spondyloarthritis (axSpA) remain a challenge; quantitative imaging biomarkers (QIBs) of inflammation could enhance assessments of disease activity and therapeutic response. We aimed to determine the responsiveness of QIBs obtained from diffusion-weighted imaging (DW-MRI) and chemical shift-encoded MRI (CSE-MRI) using the partially automated Bone Edema and Adiposity Characterisation with Histograms (BEACH) software tool in axSpA patients undergoing biologic therapy.Methods We conducted a prospective longitudinal cohort study, including 30 patients with axSpA undergoing biologic therapy. Patients were scanned before and after biologic therapy using conventional MRI, DWI and CSE-MRI at 3T. Apparent diffusion coefficient (ADC) and proton density fat fraction (PDFF) were assessed using the BEACH tool (https://github.com/TJPBray/BEACH), and conventional MR images were assessed using established visual scoring methods by expert radiologists. Responsiveness - the ability of the MRI measurements to capture changes in disease occurring as a result of biologic therapy - was assessed using the standardized response mean (SRM). Inter-reader reliability of the ADC and PDFF maps was assessed using Bland-Altman limits of agreement analysis and the intraclass correlation coefficient.Results Responsiveness to therapy was moderate for ADC-based parameters (SRM 0.50) and comparable to established visual scoring methods for bone marrow oedema (SRM 0.53). Interobserver variability was lower for QIBs compared with conventional visual scores methods.Conclusions QIBs measured using the BEACH tool are sensitive to changes in inflammation in axSpA following biologic therapy, with similar responsiveness and lower interobserver variability to visual scoring by expert radiologists.Advances in knowledge QIBs measured using the partially automated BEACH tool offer an objective measure of response to biologic therapy in axSpA.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Impact of TNF inhibitor medication on working ability in axial spondyloarthritis: an observational national registry-based cohort study
    Hokkanen, Anna-Mari
    Aaltonen, Kalle
    Relas, Heikki
    Rutanen, Jarno
    Kononoff, Aulikki
    Taimen, Kirsi
    Kauppi, Markku
    Puolakka, Kari
    Trokovic, Nina
    Nordstrom, Dan
    [J]. RHEUMATOLOGY ADVANCES IN PRACTICE, 2023, 7 (02)
  • [22] Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain
    Benavent, Diego
    Franco-Gomez, Karen
    Plasencia-Rodriguez, Chamaida
    Novella-Navarro, Marta
    Bogas, Patricia
    Nieto, Romina
    Monjo, Irene
    Nuno, Laura
    Villalba, Alejandro
    Peiteado, Diana
    Balsa, Alejandro
    Navarro-Compan, Victoria
    [J]. BMJ OPEN, 2022, 12 (04):
  • [23] Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study
    Athanassiou, Panagiotis
    Psaltis, Dimitrios
    Georgiadis, Athanasios
    Katsifis, Gkikas
    Theodoridou, Athina
    Gazi, Souzana
    Sidiropoulos, Prodromos
    Tektonidou, Maria G. G.
    Bounas, Andreas
    Kandyli, Anna
    Vounotrypidis, Periklis
    Sakellariou, Grigorios T. T.
    Vassilopoulos, Dimitrios
    Huang, Zhiping
    Petrikkou, Evangelia
    Boumpas, Dimitrios
    [J]. RHEUMATOLOGY INTERNATIONAL, 2023, 43 (10) : 1871 - 1883
  • [24] Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment
    Paramarta, Jacqueline E.
    De Rycke, Leen
    Ambarus, Carmen A.
    Tak, Paul P.
    Baeten, Dominique
    [J]. RHEUMATOLOGY, 2013, 52 (10) : 1873 - 1878
  • [25] Which Magnetic Resonance Imaging Lesions in the Sacroiliac Joints Are Most Relevant for Diagnosing Axial Spondyloarthritis? A Prospective Study Comparing Rheumatologists' Evaluations With Radiologists' Findings
    Baraliakos, X.
    Ghadir, A.
    Fruth, M.
    Kiltz, U.
    Redeker, I
    Braun, J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 800 - 805
  • [26] Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort
    Manouk de Hooge
    Roberta Ramonda
    Mariagrazia Lorenzin
    Paola Frallonardo
    Leonardo Punzi
    Augusta Ortolan
    Andrea Doria
    [J]. Arthritis Research & Therapy, 18
  • [27] Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints
    Varkas, G.
    Jans, L.
    Cypers, H.
    Van Praet, L.
    Carron, P.
    Elewaut, D.
    Van den Bosch, F.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (03) : 672 - 678
  • [28] Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort
    Ciurea, Adrian
    Kissling, Seraphina
    Buerki, Kristina
    Baraliakos, Xenofon
    de Hooge, Manouk
    Hebeisen, Monika
    Papagiannoulis, Eleftherios
    Exer, Pascale
    Bram, Rene
    Nissen, Michael J.
    Moller, Burkhard
    Kyburz, Diego
    Andor, Michael
    Distler, Oliver
    Scherer, Almut
    Micheroli, Raphael
    [J]. RMD OPEN, 2022, 8 (01):
  • [29] PREdiction and Diagnosis using Imaging and Clinical biomarkers Trial in Traumatic Brain Injury (PREDICT-TBI) study protocol: an observational, prospective, multicentre cohort study for the prediction of outcome in moderate-to-severe TBI
    Nasrallah, Fatima
    Bellapart, Judith
    Walsham, James
    Jacobson, Esther
    To, Xuan Vinh
    Manzanero, Silvia
    Brown, Nathan
    Meyer, Jason
    Stuart, Janine
    Evans, Tracey
    Chandra, Shekhar S.
    Ross, Jason
    Campbell, Lewis
    Senthuran, Siva
    Newcombe, Virginia
    McCullough, James
    Fleming, Jennifer
    Pollard, Clifford
    Reade, Michael
    [J]. BMJ OPEN, 2023, 13 (04):
  • [30] Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden
    Gulfe, A.
    Kapetanovic, M. C.
    Kristensen, L. E.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (06) : 493 - 497